NFIL3/Tim3 axis regulates effector Th1 inflammation in COPD mice.

Area of Science:

• Immunology
• Pulmonary Medicine
• Molecular Biology

Background:

• Type 1 helper T (Th1) cells, characterized by IFN-γ production, are key players in chronic obstructive pulmonary disease (COPD) lung inflammation.
• Understanding factors influencing COPD-associated Th1 cells is crucial for developing targeted therapies.

Purpose of the Study:

• To identify key regulatory genes involved in Th1 cell responses within the context of COPD.
• To elucidate the role of T-cell immunoglobulin and mucin-domain containing-3 (Tim3) and its regulatory network in COPD pathogenesis.

Main Methods:

• Single-cell sequencing and flow cytometry were employed to analyze T-cell populations in COPD models.
• Gene knockout mouse models (HAVCR2 and NFIL3) were utilized to investigate the functional significance of identified genes.
• In vitro studies involving CD4+ T cell polarization were performed to confirm regulatory mechanisms.

Main Results:

• Tim3 (encoded by Havcr2) expression was found to be upregulated on CD4+ T cells and Th1 cells during COPD progression in mice.
• HAVCR2 knockout exacerbated lung inflammation and emphysema, increasing CD4+ T cell infiltration and IFN-γ levels.
• NFIL3, an upstream regulator of Tim3, was also upregulated; NFIL3 knockout mimicked HAVCR2 knockout phenotypes and reduced Tim3 expression, while in vitro Th1 polarization upregulated NFIL3/Tim3.

Conclusions:

• The NFIL3/Tim3 axis is identified as a significant regulator of Th1 cell responses in COPD lungs.
• This axis appears to play an inhibitory role in Th1 cell differentiation, contributing to Th1 imbalance in COPD.
• Targeting the NFIL3/Tim3 pathway may offer a novel therapeutic strategy for managing COPD-related inflammation.